The 40% club

Episode notes

Gaurav, Kamil and Andrew return to discuss the latest news on the European economy. Kamil unpacks the latest trade and industrial production data and what they reveal about the impact of higher U.S. tariffs. Is the weakness just a reversal of earlier frontloading in pharmaceuticals, or are tariffs starting to bite? Meanwhile, Andrew discusses the key takeaways from the text of the EU-U.S. trade agreement and what it suggests about the likely path of tariff rates. The damage from tariffs is set to grow and uncertainty remains high, but the team share a sense that the risks of recession in Europe have receded and even manage to agree on the odds. Questions or Comments, please email us at GEU@Moodys.com. We would love to hear from you. To stay informed and follow the insights of Moody's Analytics economists, visit Economic View . Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Related episodes across the Index

Other episodes covering the same guests and topics, from across The B2B Podcast Index.

• 2025 Pricing Predictions Revisited: A Year of Tariffs, Inflation, and Pricing ScrutinyPricing Heroes · on Tariffs72 / 100
• How Brunswick's Lee Gordon Runs Comms at Warp SpeedOver A Pint Marketing Podcast · on Tariffs71 / 100
• Armada’s Prather takes a deep dive into the freight economy and tariffsSupply Chain 24/7 Podcast · on Tariffs68 / 100
• How to Turn Global Turmoil into a Competitive Supply Chain AdvantageSupply Chain Optimizers · on Tariffs59 / 100
• PE Pulse: key takeaways from Q1 2026NextWave Private Equity · on Tariffs58 / 100
• Adaptability is the New Currency of Work with Dallas CountsHRchat Podcast · on Tariffs56 / 100

• Offices and AI81 / 100
• Asia's Alphabet Soup Economies71 / 100
• Nothing Ever Happens
• Devolution, Oil and Tariffs
• Meet the Experts: Crude, Currencies and Central Banks